This content is from: Portfolio Investing in a Cure for Cancer The recently launched Loncar Cancer Immunotherapy ETF provides investors with a vehicle to bet on promising new immunotherapy treatments for cancer. By Kaitlin Ugolik June 07, 2016
This content is from: Premium Smart Routes Navigating dark pools requires specialized tools. By Irwin Speizer July 23, 2008
This content is from: Corner Office The 41% Man Perceptive Advisors’ Joseph Edelman regularly crushes markets and hedge fund peers. How? By Amanda Cantrell August 13, 2018
